Paget's Disease

Paget's disease, also called osteitis deformans, is a chronic bone disorder in which there is abnormal bone remodelling (the process of bone breakdown and rebuilding). With Paget's disease, bone is broken down more quickly and is then replaced with softer, more porous bone. As a result, affected bones become thicker, weaker, and deformed. It usually affects the bones of the skull, pelvis, collarbone, spine, and legs.

Paget's disease affects about 3% of people over the age of 40, but the exact number is not known since many people don't know they have the condition. It seems to affect more men than women. Although this disease is found around the world, it appears more commonly in Europe and Australia.

Although the exact cause of Paget's disease is unknown, it appears to run in families. Up to 30% of people with the disease have other family members who also have it. Some researches believe that a virus may be involved, but a specific virus has not been identified.

Whatever the cause, Paget's disease results in abnormal bone remodelling (the process of bone breakdown and rebuilding). In Paget's disease, when bone is broken down, it is replaced with bone that is less dense and more brittle, more prone to fracture or bowing, and enlarged.

Most people with Paget's disease have no symptoms. When symptoms do occur, the most common symptom is bone pain. When Paget's only involves one area, it is called monoostotic. When it involves more than one area of the skeleton it is called polyostotic. Other symptoms associated with Paget's disease include:

joint pain (if Pagetic bone is connected to the joint)

bone fractures

bone deformities (e.g., enlarged head, bowed legs, reduced height)

pain or numbness (from pressure on nerves)

headache

hearing loss (when abnormally formed skull bones press on the nerve)

warmth over an affected area

fatigue

Unless Paget's disease shows up on an X-ray taken for some other reason, people often don't know they have it. Later on, chronic bone pain becomes the most common symptom of the disease. The bones are tender to touch, and become large and deformed. They also break easily, require a long time to heal, and are malformed when they do heal.

Enlarged spinal bones may press on sensory nerves, causing pain and sometimes cutting off all feeling in the legs. Enlarged bones in the head can put pressure on nerves leading to tinnitus (ringing or noises in the ear), dizziness, and headaches.

Paget's disease usually progresses slowly. Complications from this disorder can include:

osteoarthritis (a degenerative joint disease)

heart failure (only in cases of advanced polyostotic Paget's disease due to the increased blood flow putting extra demand on the heart and blood circulation)

bone cancer (rarely)

kidney stones

hypercalcemia (high levels of calcium in the blood; this usually occurs in severe cases and if a person is immobilized for a long time)

People with Paget's disease may be first diagnosed from blood work, X-rays, or bone scans that are done for other reasons. This is because in the early stages of Paget's disease, there are usually no symptoms. X-rays will show areas of thick, porous bone and other areas with thinner bone, depending on the stage of the disease. The blood tests will show high levels of alkaline phosphatase, an enzyme used in forming bones.

Noticing this condition early is important to help reduce the number and severity of complications that are associated with this condition.

Doctors may not recommend treatment until symptoms appear. When symptoms appear or are affecting a high-risk part of the body, or if blood tests reveal a high level of alkaline phosphatase, treatment may be started to slow disease progression and help prevent complications.

There is no cure for the disease, although various treatments relieve or control the symptoms. Medications known as bisphosphonates (e.g., alendronate*, etidronate, and risedronate) may be recommended for people with Paget's disease. These medications are also used to treat osteoporosis, but for Paget's disease, they are given in higher doses and more frequently than for osteoporosis.

Zoledronic acid and pamidronate are also used to treat Paget's disease. These medications help rebuild normal bone and relieve pain.

Pain-relieving medications such as acetaminophen and nonsteroidal anti-inflammatory drugs (NSAIDs) may also be used. It is very important that people with Paget's disease take in adequate amounts of calcium and vitamin D. Your doctor may suggest supplements if appropriate.

Some people with severe Paget's disease may require surgery to repair bone deformities, joints, or broken bones, or to replace joints.

Exercise can help decrease joint stiffness. Some types of exercise are not recommended for people with Paget's disease, so talk to your doctor before starting an exercise program. Heat and cold can help with pain – heat helps relieve aching muscles, pain, and stiffness, and cold can help reduce inflammation and pain.

*All medications have both common (generic) and brand names. The brand name is what a specific manufacturer calls the product (e.g., Tylenol®). The common name is the medical name for the medication (e.g., acetaminophen). A medication may have many brand names, but only one common name. This article lists medications by their common names. For information on a given medication, check our Drug Information database. For more information on brand names, speak with your doctor or pharmacist.

Products cannot be purchased on this website and may not be available at all stores. Prices shown in the e-flyers reflect regional pricing. Stores may sell for less. Product availability may vary by store. Please contact your nearest store for availability and quantity limitations. Shoppers Drug Mart has updated its privacy policy to include its new retail store, Wellwise™, and to reflect the recent amendments to Canada's Personal Information Protection and Electronic Documents Act pertaining to the sharing of personal information in the context of a business transaction. The new privacy policy is effective November 1, 2017.